Ace the 2026 ROSH GI Challenge – Master the Gut and Own the Exam!

CA 19-9 antigen is a commonly used laboratory marker that assists in the diagnosis and monitoring of pancreatic cancer. This carbohydrate antigen is often elevated in the presence of pancreatic malignancies, making it a valuable tool in clinical practice. Its levels in the blood can help physicians assess the likelihood of pancreatic cancer, especially when patients present with symptoms indicative of the disease, such as unexplained weight loss, abdominal pain, or jaundice.

While the other options may provide some clinical value in different contexts, they are not specific or routinely used in the diagnosis of pancreatic cancer. AST and ALT are liver enzymes that primarily indicate liver function or liver damage, and while they can be elevated in various conditions, they are not specific to pancreatic cancer. Total bilirubin can indicate biliary obstruction or liver disease but does not provide direct evidence for pancreatic cancer itself. Therefore, the elevation of CA 19-9 antigen specifically correlates with pancreatic cancer, making it the most relevant laboratory marker for this condition.